GT BIOPHARMA, INC. Earnings Per Share (Diluted)
GT BIOPHARMA, INC. (GTBP) reported Earnings Per Share (Diluted) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- GT BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.12.
- GT BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.11.
- GT BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.44.
- GT BIOPHARMA, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $1.04.
- GT BIOPHARMA, INC. earnings per share, diluted for fiscal 2025 was -$6.68.
- GT BIOPHARMA, INC. earnings per share, diluted for fiscal 2024 was -$6.94.
- GT BIOPHARMA, INC. earnings per share, diluted for fiscal 2023 was -$5.64.
- GT BIOPHARMA, INC. earnings per share, diluted for fiscal 2022 was -$19.66.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.12 10-Q · filed 2026-08-14 | -$0.23 10-Q · filed 2026-08-14 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.11 10-Q · filed 2026-05-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$2.43 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-07-02 | $0.31 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$4.20 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$6.68 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $1.04 10-Q/A · filed 2026-03-06 | -$0.83 10-Q · filed 2025-11-14 | -$6.52 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$8.90 10-Q/A · filed 2026-03-06 | -$1.84 10-Q · filed 2025-11-14 | -$9.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-06-30 | -$10.92 10-Q · filed 2026-08-14 | -$0.55 10-Q · filed 2025-08-14 | -$12.12 10-Q · filed 2026-08-14 | -$0.90 10-Q · filed 2025-08-14 | -$14.12 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$15.87 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-03-31 | -$0.33 10-Q · filed 2026-05-15 | -$1.98 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$3.49 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$5.46 derived: net income ÷ weighted average shares · filed 2026-07-02 | ||||
| 2024-12-31 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$3.20 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$5.27 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$6.94 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | -$1.53 10-Q/A · filed 2026-03-06 | -$3.61 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$5.28 10-Q/A · filed 2026-03-06 | -$7.36 derived: net income ÷ weighted average shares · filed 2026-07-02 | ||||
| 2024-06-30 | -$2.17 10-Q/A · filed 2026-03-06 | -$3.86 10-Q/A · filed 2026-03-06 | -$5.99 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$7.78 derived: net income ÷ weighted average shares · filed 2026-07-02 | ||||
| 2024-03-31 | -$1.64 10-Q · filed 2025-05-15 | -$3.79 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$5.55 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$7.05 derived: net income ÷ weighted average shares · filed 2026-07-02 | ||||
| 2023-12-31 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$3.91 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$5.41 derived: net income ÷ weighted average shares · filed 2026-07-02 | -$5.64 10-K · filed 2025-02-21 | ||||
| 2023-09-30 | -$1.77 10-Q · filed 2024-11-14 | -$0.06 10-Q · filed 2023-11-01 | -$3.26 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$3.47 10-Q · filed 2024-11-14 | -$0.12 10-Q · filed 2023-11-01 | $0.47 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$1.49 10-Q · filed 2024-08-14 | -$0.05 10-Q · filed 2023-08-07 | -$1.68 10-Q · filed 2024-08-14 | -$0.06 10-Q · filed 2023-08-07 | $0.26 derived: net income ÷ weighted average shares · filed 2024-08-14 | $1.03 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||
| 2023-03-31 | -$0.21 10-Q · filed 2024-05-15 | $0.13 derived: net income ÷ weighted average shares · filed 2024-05-15 | $0.65 derived: net income ÷ weighted average shares · filed 2024-05-15 | $2.30 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2024-03-26 | $0.42 derived: net income ÷ weighted average shares · filed 2024-03-26 | $1.64 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$19.66 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | -$0.22 10-Q · filed 2023-11-01 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$0.48 10-Q · filed 2023-11-01 | |||||
| 2022-06-30 | -$0.10 10-Q · filed 2023-08-07 | -$0.26 10-Q · filed 2023-08-07 | ||||||
| 2020-12-31 | -$6.45 derived: net income ÷ weighted average shares · filed 2022-03-28 | |||||||
| 2020-03-31 | -$0.02 10-Q · filed 2020-05-15 | |||||||
| 2019-12-31 | -$11.42 derived: net income ÷ weighted average shares · filed 2021-04-16 | |||||||
| 2019-03-31 | -$0.09 10-Q · filed 2020-05-15 | $0.18 derived: net income ÷ weighted average shares · filed 2020-05-15 | $14.99 derived: net income ÷ weighted average shares · filed 2020-05-15 | $20.73 derived: net income ÷ weighted average shares · filed 2020-05-15 | ||||
| 2018-12-31 | $0.03 derived: net income ÷ weighted average shares · filed 2020-03-27 | $4.80 derived: net income ÷ weighted average shares · filed 2020-03-27 | $7.47 derived: net income ÷ weighted average shares · filed 2020-03-27 | -$5.16 10-K · filed 2019-03-29 | ||||
| 2018-09-30 | -$4.70 10-Q · filed 2018-11-14 | -$9.76 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$5.09 10-Q · filed 2018-11-14 | -$12.51 derived: net income ÷ weighted average shares · filed 2019-11-14 | ||||
| 2018-06-30 | $50117977.00 10-Q · filed 2018-08-14 | $50117977.00 10-Q · filed 2018-08-14 | -$2.27 derived: net income ÷ weighted average shares · filed 2019-08-14 | -$12.64 derived: net income ÷ weighted average shares · filed 2019-08-14 | ||||
| 2018-03-31 | -$0.20 10-Q · filed 2019-05-15 | -$0.97 derived: net income ÷ weighted average shares · filed 2019-05-15 | -$8.92 derived: net income ÷ weighted average shares · filed 2019-05-15 | -$12.10 derived: net income ÷ weighted average shares · filed 2019-05-15 | ||||
| 2017-12-31 | $0.36 derived: net income ÷ weighted average shares · filed 2019-03-29 | $345.59 derived: net income ÷ weighted average shares · filed 2019-03-29 | $527.73 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$8.60 10-K · filed 2019-03-29 | -$8.54 10-K · filed 2018-03-01 | |||
| 2017-09-30 | -$8.15 10-Q · filed 2018-11-14 | -$8.24 10-Q · filed 2017-11-14 | -$16.61 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$24.54 10-Q · filed 2018-11-14 | -$24.38 10-Q · filed 2017-11-14 | $10.97 derived: net income ÷ weighted average shares · filed 2018-11-14 | ||
| 2017-06-30 | $479053.00 10-Q · filed 2018-08-14 | -$5.91 10-Q · filed 2017-08-11 | $335450.00 10-Q · filed 2018-08-14 | -$15.34 10-Q · filed 2017-08-11 | $0.46 derived: net income ÷ weighted average shares · filed 2018-08-14 | $1.40 derived: net income ÷ weighted average shares · filed 2018-08-14 | ||
| 2017-03-31 | -$26.36 10-Q · filed 2018-05-15 | -$0.04 10-Q · filed 2017-04-28 | $0.23 derived: net income ÷ weighted average shares · filed 2018-05-15 | $0.86 derived: net income ÷ weighted average shares · filed 2018-05-15 | $2.74 derived: net income ÷ weighted average shares · filed 2018-05-15 | |||
| 2016-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.32 derived: net income ÷ weighted average shares · filed 2018-03-01 | $1.00 derived: net income ÷ weighted average shares · filed 2018-03-01 | $119.91 10-K · filed 2018-03-01 | $0.40 10-K/A · filed 2018-02-28 | |||
| 2016-09-30 | $0.13 10-Q/A · filed 2018-02-28 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-02-28 | $0.56 10-Q/A · filed 2018-02-28 | $1.05 10-Q · filed 2016-11-14 | -$0.82 derived: net income ÷ weighted average shares · filed 2018-02-28 | |||
| 2016-06-30 | $0.06 10-Q/A · filed 2018-02-28 | $25407055.00 10-Q · filed 2016-08-10 | $0.72 10-Q/A · filed 2018-02-28 | $22446848.00 10-Q · filed 2016-08-10 | -$0.78 derived: net income ÷ weighted average shares · filed 2018-02-28 | -$1.14 derived: net income ÷ weighted average shares · filed 2018-02-28 | ||
| 2016-03-31 | $0.84 10-Q/A · filed 2018-02-28 | $1.49 10-Q · filed 2016-05-13 | -$1.80 derived: net income ÷ weighted average shares · filed 2018-02-28 | -$2.61 derived: net income ÷ weighted average shares · filed 2018-02-28 | $2.75 derived: net income ÷ weighted average shares · filed 2018-02-28 | |||
| 2015-12-31 | $5.54 derived: net income ÷ weighted average shares · filed 2018-02-28 | $24.01 derived: net income ÷ weighted average shares · filed 2018-02-28 | -$1.09 derived: net income ÷ weighted average shares · filed 2018-02-28 | -$8.96 10-K/A · filed 2018-02-28 | ||||
| 2015-09-30 | $0.71 10-Q/A · filed 2018-02-28 | $0.00 10-Q · filed 2015-11-13 | $6.89 derived: net income ÷ weighted average shares · filed 2018-02-28 | $0.98 10-Q/A · filed 2018-02-28 | $0.00 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | $5.47 10-Q/A · filed 2018-02-28 | $0.02 10-Q · filed 2015-08-14 | $1.29 10-Q/A · filed 2018-02-28 | $0.01 10-Q · filed 2015-08-14 | ||||
| 2015-03-31 | -$8.61 10-Q/A · filed 2018-02-28 | $0.03 10-Q · filed 2015-05-14 | ||||||
| 2014-09-30 | -$0.01 10-Q · filed 2015-11-13 | $0.00 10-Q · filed 2015-01-08 | -$0.01 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$0.01 10-Q · filed 2015-11-13 | $0.00 10-Q · filed 2015-01-08 | |||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | |||||||
| 2013-09-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-01-08 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-01-08 | $0.00 10-Q · filed 2015-01-08 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2015-01-08 | $0.00 10-Q · filed 2015-01-08 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2015-01-08 | |||||||
| 2012-06-30 | -$0.01 10-Q · filed 2014-12-12 | -$0.01 10-Q · filed 2014-12-12 | ||||||
| 2012-03-31 | $0.00 10-Q · filed 2014-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |